Organisation paid for research Program year 2025 Source: CMS Open Payments

Rochester Ophthalmological Group

Neither a doctor nor a teaching hospital

Research payments

$212,333

183 payments

Through program year 2025, Rochester Ophthalmological Group is reported as receiving $212,333 in research payments, across 183 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$65,100	11
2023	Research	$13,155	1
2021	Research	$17,394	21
2020	Research	$100,115	139
2019	Research	$16,569	11

Breakdown

Who paid Research payments · program years 2019–2025

Alcon Research LLC $127,541 169 payments
Oyster Point Pharma, Inc. $65,100 11 payments
AbbVie, Inc. $13,155 1 payment
Osmotica Pharmaceutical Corp. $6,538 2 payments

Studies the money was for Research payments · program years 2019–2025

Mercury Extended Wear Registration Trial(Weekly SiHy NW Sphere (Mercury)) $110,147 148 payments
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) $55,200 8 payments
Assessment of an Investigational Frequent Replacement Silicone Hydrogel Lens $17,394 21 payments
Long-term Safety and Efficacy Extension Trial of Bimatoprost SR $13,155 1 payment
Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia (VEGA-3) $9,900 3 payments
Rvl-203 $6,538 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.